News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

67,923 Results

Type

Article (1927)
Company Profile (1)
Press Release (65995)

Section

Business (21412)
Career Advice (9)
Deals (4553)
Drug Development (8146)
FDA (1794)
Job Trends (799)
News (36911)
Policy (3566)

Tag

Date

Today (9)
Last 7 days (54)
Last 30 days (195)
Last 365 days (3670)
2024 (2066)
2023 (3814)
2022 (7016)
2021 (6373)
2020 (5876)
2019 (3875)
2018 (3012)
2017 (3561)
2016 (3174)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2776)
2011 (2902)
2010 (2663)

Filters

Type

Article (1927)
Company Profile (1)
Press Release (65995)

Section

Business (21412)
Career Advice (9)
Deals (4553)
Drug Development (8146)
FDA (1794)
Job Trends (799)
News (36911)
Policy (3566)

Tag

Date

Today (9)
Last 7 days (54)
Last 30 days (195)
Last 365 days (3670)
2024 (2066)
2023 (3814)
2022 (7016)
2021 (6373)
2020 (5876)
2019 (3875)
2018 (3012)
2017 (3561)
2016 (3174)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2776)
2011 (2902)
2010 (2663)

67,923 Results for "kamada ltd".

Sort By

Business

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Kamada Ltd. announced that it will release financial results for the first quarter ended March 31, 2024, prior to the open of the U.S. financial markets on Wednesday, May 8, 2024.

May 1, 2024
·
2 min read
Pharm Country

Kamada Issues 2024 CEO Letter to Shareholders

Kamada Ltd., a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, issued a Letter to Shareholders from Amir London, Chief Executive Officer.

March 6, 2024
·
18 min read
Business

Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance

Kamada Ltd., a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced financial results for three months ended March 31, 2024.

May 8, 2024
·
18 min read
Business

Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability

Kamada Ltd. announced financial results for the three months and year ended December 31, 2023.

March 6, 2024
·
21 min read
Business

Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024Company to Host Conference Call at 8:30am ET

Kamada Ltd. announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2023, as well as provide 2024 financial guidance, prior to the open of the U.S. financial markets on Wednesday, March 6, 2024.

February 28, 2024
·
3 min read
Kedrion Announces an Eight-Year Extension of the Distribution Agreement With Kamada in the US for KEDRAB®

Kedrion Biopharma announces the execution of a binding memorandum of understanding with Kamada Ltd., an Israeli commercial stage global biopharmaceutical company and leader in the specialty plasma-derived field, for the amendment and the 8-year extension of the KEDRAB® US distribution agreement between the two companies.

December 7, 2023
·
5 min read
Business

Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance

Kamada Ltd. announced financial results for the three and nine months ended September 30, 2023.

November 13, 2023
·
21 min read
Business

Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years

Kamada Ltd. announced the execution of a binding memorandum of understanding with Kedrion for the amendment and extension of the KEDRAB® U.S. distribution agreement between the parties.

December 6, 2023
·
8 min read
Pharm Country

Kamada Provides Corporate Update on its Israel Operations

Kamada Ltd. today announced that while circumstances in Israel are evolving, the Company continues to conduct its business operations in Israel with no effect on business continuity, and its global supply of products is not expected to be interrupted.

October 10, 2023
·
4 min read
Pharm Country

Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds

Kamada Ltd. announced shareholder approval and planned closing of the previously announced $60 million private placement with FIMI Opportunity Funds, the leading private equity firm in Israel and a large existing Kamada shareholder.

August 30, 2023
·
7 min read

1 of 6,793

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin